FREE OVERNIGHT SHIPPING
Meet Tirzepatide Plus, our advanced weight loss formula that combines the cutting-edge power of Tirzepatide with Niacinamide (Vitamin B3) to enhance your health and wellness. Specifically compounded for Willow patients, this innovative blend offers more than just weight loss.
While Tirzepatide works to regulate blood sugar, suppress appetite, and promote fat loss, Niacinamide provides targeted support for your weight loss journey. It helps improve energy production, supports healthy metabolism, and enhances skin health, ensuring you feel and look your best as you achieve your goals.
Tirzepatide Plus offers a holistic approach to weight loss, helping you shed pounds effectively while supporting overall vitality and wellness.
CA, WI, and IA residents will receive Tirzepatide Plus with L-Carnitine. This GLP-1 blend features a full dose of Tirzepatide, enhanced with L-Carnitine to support weight loss and preserve lean muscle mass.
Niacinamide, a form of Vitamin B3, is a vital nutrient that plays a key role in energy production, metabolism, and cellular repair. It supports your body’s natural ability to convert food into energy and helps maintain healthy skin, reduce inflammation, and promote overall wellness. This makes Niacinamide an excellent addition for those looking to enhance their weight loss and health journey.When combined with tirzepatide, Niacinamide offers a comprehensive approach to weight management.
While tirzepatide helps regulate blood sugar levels and suppress appetite, Niacinamide supports your body's metabolic processes, ensuring sustained energy and promoting a healthy balance throughout your journey. This combination not only aids in effective and steady weight loss but also supports cellular health and overall vitality. Together, tirzepatide and Niacinamide work synergistically to help you achieve your weight loss goals while enhancing your overall health and well-being.
Semaglutide and tirzepatide are both medications used for weight loss, but they have distinct differences.
Semaglutide is a GLP-1 receptor agonist, which helps to regulate blood sugar by enhancing insulin secretion, slowing gastric emptying, and promoting satiety.
Tirzepatide, on the other hand, is a dual agonist, targeting both the GLP-1 and GIP receptors, offering enhanced glucose control and weight loss by combining the effects of both incretin hormones. Clinical trials suggest that tirzepatide offers superior efficacy in both glucose lowering and weight reduction compared to semaglutide.
Tirzepatide is a novel medication that works by targeting two key receptors involved in glucose and energy regulation: the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor.
By activating these receptors, Tirzepatide enhances insulin secretion in response to meals, inhibits glucagon release, and slows gastric emptying, which helps to control blood sugar levels. Additionally, it promotes feelings of fullness and reduces appetite, leading to weight loss.
The dual agonist action of Tirzepatide leverages the complementary effects of GLP-1 and GIP, resulting in improved glycemic control and significant weight reduction in patients.
Results could mark a "new era" in treating obesity with even more therapies on the horizon.
The most effective drug intervention we have seen for weight management.
In studies, a weekly injection caused dramatic amounts of weight loss and improved other heart-related risk factors.
2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.
.png)
These highly effective anti-obesity medications are associated with weight losses of more than 10% of overall bodyweight in more than two-thirds of clinical trial participants.
Results could mark a "new era" in treating obesity with even more therapies on the horizon.
The most effective drug intervention we have seen for weight management.
In studies, a weekly injection caused dramatic amounts of weight loss and improved other heart-related risk factors.
2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.
These highly effective anti-obesity medications are associated with weight losses of more than 10% of overall bodyweight in more than two-thirds of clinical trial participants.
Results could mark a "new era" in treating obesity with even more therapies on the horizon.
The most effective drug intervention we have seen for weight management.
In studies, a weekly injection caused dramatic amounts of weight loss and improved other heart-related risk factors.
2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.
These highly effective anti-obesity medications are associated with weight losses of more than 10% of overall bodyweight in more than two-thirds of clinical trial participants.
We believe in a sustainable and flexible approach to nutrition, without imposing limitations on your diet. Our goal is to guide you in establishing healthy eating habits, complemented by the medication's ability to decrease appetite and “food noise”. We encourage maintaining a nourishing, high-protein diet, but most patients are able to lose weight without the need for uncomfortably restrictive dieting or calorie counting.
Common side effects of tirzepatide are usually mild and may include:
• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Decreased appetite
• Indigestion
The majority of side effects are transient and typically resolve spontaneously. Nevertheless, if side effects persist or deteriorate, seek guidance from a healthcare professional.
Willow also offers Odansetron to manage side effects if they occur. This medication is commonly used to prevent nausea and vomiting.
Tirzepatide Patient Safety Information
When stopping Tirzepatide abruptly, some patients may experience mild to moderate weight gain. Others may maintain the weight loss they achieved while on the medication. We recommend patients work with their Willow physician to slowly decrease their dose in order to maintain their weight loss achievements.
You may notice an increase in appetite and a return of food cravings, allowing you to eat more without feeling as full. However, stopping Tirzepatide is a safe and common practice that doesn't involve serious health risks. By gradually tapering off the medication with your physician’s guidance, you can better manage these changes and maintain your health and wellness goals.
Tirzepatide is administered once a week via a subcutaneous injection. Don’t worry! The needle is very small and short, making self-injection quick & easy. We’ll provide you with detailed written and video instructions that make the process simple and easy to follow. We even include a link to a soothing Spotify playlist to play in the background if you wish.
